SCHEMBL4687956

SCHEMBL4687956

O=C1C(Cc2ccccc2)c2ccccc2N1c1cc(Cl)cc(Cl)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 5/20 0.50
ITGB2 P05107 1/20 0.45
ICAM1 P05362 1/20 0.45
ITGAL P20701 1/20 0.45
EP300 Q09472 1/20 0.43
CES2 O00748 4/20 0.39
GAA P10253 2/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2C19 P33261 1/20 0.39
MEN1 O00255 1/20 0.38
ALDH1A1 P00352 1/20 0.38
MAPT P10636 1/20 0.38
ALOX15 P16050 1/20 0.38
ALOX12 P18054 1/20 0.38
KMT2A Q03164 1/20 0.38
HSD17B10 Q99714 1/20 0.38
MMP2 P08253 1/20 0.37
NR1H2 P55055 1/20 0.37
SMO Q99835 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4692248 0.91 ALOX5 (0.47) ALOX5ITGB2ICAM1ITGALCES2
SCHEMBL4693030 0.86 GAA (0.39) ALOX5ITGB2ICAM1ITGALEP300
SCHEMBL4690051 0.83 ALOX5 (0.46) ALOX5ITGB2ICAM1ITGALCES2
SCHEMBL4687618 0.81 ITGB2 (0.41) ALOX5ITGB2ICAM1ITGALEP300
SCHEMBL29158505 0.81 ALDH1A1 (0.55) ALOX5CES2GAACYP1A2CYP3A4
SCHEMBL9719342 0.80 ALOX5 (0.47) ALOX5CYP1A2CYP3A4CYP2C19MEN1
SCHEMBL4688597 0.78 ALOX5 (0.48) ALOX5ITGB2ICAM1ITGALCES2
SCHEMBL4599210 0.78 ALDH1A1 (0.48) ALOX5CES2GAACYP1A2CYP3A4
Hydrochloric Acid SCHEMBL8805740 0.77 MAPK1 (0.48) ALOX5CES2GAACYP1A2CYP3A4
SCHEMBL9719340 0.75 GSK3B (0.51) ALOX5CES2GAACYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1399155-B1 SMALL MOLECULES USEFUL IN THE TREATMENT OF INFLAMMATORY DISEASE BOEHRINGER INGELHEIM PHARMA (US) 2008-05-28 EP claimed
US-6414153-B1 TREATMENT OF INFLAMMATORY OR IMMUNE CELL-MEDIATED DISEASE OR CONDITION BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. 2002-07-02 US claimed
EP-1399155-B1 SMALL MOLECULES USEFUL IN THE TREATMENT OF INFLAMMATORY DISEASE BOEHRINGER INGELHEIM PHARMA (US) 2008-05-28 EP disclosed
US-6414153-B1 TREATMENT OF INFLAMMATORY OR IMMUNE CELL-MEDIATED DISEASE OR CONDITION BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. 2002-07-02 US disclosed